PTGDR2 and neoplasm: Given its established role as an inflammation marker, GPR44 is being investigated for its relevance in understanding the biological behavior of the tumor, including breast cancer [14], colorectal cancer [15], hepatocellular carcinoma [16], gastric cancer [17], leukemia [18], lung cancer [19], and myeloma [20].